000009586 001__ 9586
000009586 005__ 20240409134926.0
000009586 0247_ $$2DOI$$a10.6083/5999n424n
000009586 037__ $$aIR
000009586 245__ $$aInpatient administration of IV bisphosphonate therapy for treatment of osteoporosis in elderly hip fracture patients - quality improvement initiative
000009586 260__ $$bOregon Health and Science University
000009586 269__ $$a2022
000009586 336__ $$aAbstract
000009586 520__ $$aThe American Academy of Orthopaedic Surgeons recommends that elderly patients who sustain a hip fracture should be evaluated and treated for osteoporosis. Despite research supporting the use of bisphosphonates for osteoporosis treatment and secondary fracture prevention in elderly patients, osteoporosis continues to be under-diagnosed and inadequately treated. Our quality improvement initiative aims to increase OHSU?s rate of successfully implementing bisphosphonate therapy by developing and implementing an inpatient protocol facilitating appropriate osteoporosis diagnosis and administration of a one-time intravenous bisphosphonate infusion for elderly patients admitted for hip fracture surgery.
000009586 540__ $$fCC BY
000009586 542__ $$fIn copyright - joint owners
000009586 650__ $$aQuality Improvement$$039456
000009586 650__ $$aOsteoporosis$$023359
000009586 650__ $$aHip Fractures$$020213
000009586 6531_ $$azoledronate
000009586 6531_ $$aiv bisphosphonates
000009586 7001_ $$aTurner, Naomi$$uOregon Health and Science University$$041354
000009586 7001_ $$aSong Mayeda, Marisa$$uOregon Health and Science University$$041354
000009586 7001_ $$aDrago, Katie$$uOregon Health and Science University$$041354
000009586 7001_ $$aDoung, Yee-Cheen$$uOregon Health and Science University$$041354
000009586 711__ $$aResearch Week$$uOregon Health and Science University$$d2022
000009586 8564_ $$9029d2b81-ddd0-46c3-983e-5cad663f5839$$s28989$$uhttps://digitalcollections.ohsu.edu/record/9586/files/SongMayeda-Marissa-OHSU-ResearchWeek-2022.pdf
000009586 905__ $$a/rest/prod/59/99/n4/24/5999n424n
000009586 980__ $$aResearch Week